Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT study
Nephrology Dialysis Transplantation, 03/05/2012
Clinical Article
Ketteler M et al. – Paricalcitol versus cinacalcet plus low–dose vitamin D provided superior control of intact parathyroid hormone, with low incidence of hypercalcaemia.



